Literature DB >> 8373920

Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition.

S B Schwarzkopf1, J S Lamberti, D A Smith.   

Abstract

The acoustic startle response (ASR) and midlatency auditory evoked potentials (AEP) have been utilized in the measurement of sensory inhibition. Using these different paradigms, abnormalities suggesting a lack of normal inhibition have been noted in a number of psychiatric syndromes. To date, the most commonly used sensory inhibition paradigms have not been studied in the same individuals, making generalizations across studies tenuous. In this report, reduction of ASR over multiple trials (habituation), prepulse inhibition (PPI) of ASR (decrease in ASR caused by low intensity prepulses) and P50 suppression (P50 AEP amplitude reduction in a paired-click paradigm) were measured in the same individuals. Relationships between these measures of acoustic startle and AEP inhibition were then assessed. Twenty subjects with no personal history of psychiatric disorder were tested and exhibited significant habituation and PPI of ASR as well as P50 suppression. Habituation of ASR was significantly and positively correlated with P50 suppression early, but not late, in AEP testing. Only a modest trend for a positive association between PPI and P50 suppression was noted. Habituation and PPI of startle were both highly correlated (positively) with P50 AEP amplitude. Habituation of startle remained significantly predictive of P50 suppression after controlling for P50 amplitude, whereas the modest association between PPI and P50 suppression was removed when P50 amplitude was factored out. Results indicate that habituation of acoustic startle, but not PPI, is highly associated with P50 suppression in control subjects. An unexpected finding was a robust positive correlation between P50 amplitude and both measures of startle inhibition. These findings and methodologic issues are discussed in terms of possible neural substrates involved in different measures of sensory inhibition.

Entities:  

Mesh:

Year:  1993        PMID: 8373920     DOI: 10.1016/0006-3223(93)90023-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  24 in total

1.  Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.

Authors:  Signe Düring; Birte Y Glenthøj; Gitte Saltoft Andersen; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2014-07-23       Impact factor: 7.853

2.  Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder.

Authors:  Cecilie Koldbæk Lemvigh; Jens Richardt Møllegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Birte Yding Glenthøj; Jacob Rydkjær; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-10-24       Impact factor: 7.853

3.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 4.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

Review 5.  Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

6.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

7.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

8.  Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.

Authors:  Michelle R Breier; Brittanni Lewis; Jody M Shoemaker; Gregory A Light; Neal R Swerdlow
Journal:  Behav Brain Res       Date:  2010-01-18       Impact factor: 3.332

9.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

10.  Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.

Authors:  Jacob A S Vorstman; Bruce I Turetsky; Monique E J Sijmens-Morcus; Monique G de Sain; Bert Dorland; Mirjam Sprong; Eric F Rappaport; Frits A Beemer; Beverly S Emanuel; René S Kahn; Herman van Engeland; Chantal Kemner
Journal:  Neuropsychopharmacology       Date:  2008-09-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.